- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
34 Cards in this Set
- Front
- Back
|
RNA has to undergo modifications before proteins can be
|
translated
|
|
Eukaryotes have Separate compartments for
|
transcription and translation
|
|
RNA polymeraseII has ____subunits
|
12
|
|
Types of eukaryotic RNA
|
mRNA: messenger RNA
–Template for protein synthesis (i.e. translation) •tRNA: transfer RNA – carries amino acids to the ribosome •rRNA: ribosomal RNA –Major component of ribosome and plays a structural and functional role |
|
transcribes 18S, 5.8S and 28S rRNA
|
RNA polymerase I
|
|
transcribes mRNA other snRNAs
|
RNA polymerase II
|
|
transcribes 5S rRNA and all tRNA
|
RNA polymerase III
|
|
-aminitin (produced by the poisonous mushroom Amanita phalloides) strongly inhibits RNA polymerase___
|
RNA polymerase II
|
|
Processing of mRNA transcript requires:
|
•5‟ cap
•3‟ polyA tail •Splicing |
|
7-Methylguanosine, m7Gppp is?
|
5´-CAP Structure of Eukaryotic mRNA
|
|
Transcript termination involves the addition of
|
a poly(A)250 tail.
|
|
mRNA transport
|
Mature mRNA is transported out of the nucleus to be translated in the cytoplasm.
•Proteins build based upon the code on mRNA |
|
Genes coding for proteins comprise of only___ of the human genome.
|
2%
|
|
The half-life of mRNA is an important determinant of gene expression since
|
the amount of time an mRNA can be translated will also determine the amount of protein product made
|
|
The half-life of an mRNA also determines how
|
rapidly the synthesis of the encoded protein can be shut down after transcription ceases.
|
|
of mRNA is achieved by the coordinate interactions between an RNA‟s structural components and specific trans-acting factors (RNA binding proteins).
|
The regulated decay
|
|
Different mRNAs can be degraded via
|
distinct pathways while a given mRNA can also be degraded by different, seemingly-redundant pathways, depending upon cellular conditions.
|
|
mRNA structural components include
|
5‟-Cap structure
5‟-UTR Protein coding region 3‟-UTR 3‟-Poly(A) tail |
|
mRNA decay pathways
|
•Deadenylation dependent pathway
•Deadenylation independent pathway •Nonsense mediated decay •mRNA instability elements |
|
In the Deadenylation-Dependent Pathways that have been characterized
|
poly(A) shortening is followed by decapping and both 5„3' and 3„5' exonucleolytic decay.
|
|
Some mammalian mRNAs (like insulin-like growth factor 2 (IGF2) and transferrin receptor (TfR)) are degraded by endonucleolytic activities independent of deadenylation.
|
Following endonucleolytic cleavage, the resulting 5'-fragment is targeted for 3„5' degradation activity (vulnerable 3'-OH end), while the 3'-fragment may be a substrate for a 5„3' degradation activity (vulnerable 5'-end).
|
|
Transcripts that harbor nonsense codons, unspliced introns or extended 3'-UTRs are targets for the NMD pathway.
|
In yeast, this pathway involves deadenylation-independent decapping followed by 5„3' degradation. At this point, the sequence of degradation steps involved in NMD in mammalian cells is unknown.
|
|
What Are mRNA Instability Determinants?
|
A + U-Rich Elements (AREs)
The ARE’s have been recognized as a potent destabilizing elements in a wide variety of short-lived mRNAs like those of proto-oncogenes and cytokines. The A + U-rich motif, located in the 3'-UTR of mRNAs is described by a variable number of overlapping AUUUA pentamers, frequently harbored in or about a U-rich region. |
|
The 5'-UTR can play significant roles in altering stability either in
|
a translation-dependent manner by containing translation-inhibiting stem-loops, or in a manner independent of translation.
|
|
prevents the translation of defective -globin mRNAs.
Important in modulating the severity of -thalassemia phenotype (NMD) |
mRNA stability mechanisms and surveillance
|
|
A posttranscriptional modification resulting in an alteration of the primary nucleotide sequence of RNA transcripts by a mechanism other than splicing. The process may involve the modification, insertion, deletion, or substitution of nucleotides in the RNA molecule.
|
RNA EDITING
|
|
ROLES OF RNA EDITING:
|
mRNA translation
pre-mRNA splicing RNA Degradation RNA Replication RNA Structure |
|
Mechanism of Apolipoprotein B mRNA Editing
|
makes two different proteins, ApoB48 in the intestine and ApoB100 in the Liver. Due to the Cytidine Deaminase Editing Complex (ACTIVE) in the intestine.
|
|
are ~20nt long RNAs
•Formed from larger double stranded or hairpin structure RNAs by an cytoplasmic endonuclease DICER. •miRNA binds to complementary mRNA with the aid of RNA-induced silencing complex (RISC) •The imperfect miRNA-mRNA duplex represses translation. |
miRNA
|
|
miRNA applications
|
* cell death and cell proliferation.
* many of which are involved in initiation and progression of cancer * developed for targeting specific genes to turn off their translation e.g. for BCL-2 oncogene, PTEN tumor suppressor etc. |
|
siRNA (RNAi)
|
complementary to mRNA.
The siRNA-mRNA complex results in cleavage and inactivation of the target mRNA. •The RISC endonuclease which cleaves the mRNA is called SLICER. |
|
siRNA applications
|
siRNA can be custom-synthesized to target your favorite gene
•Widespread use in disease models of diabetes, neurodegenerative disease, metabolic disorders etc. •In vivo application issues such as stability, efficacy and delivery methods. |
|
Short hairpin RNAs (shRNAs)
|
packaged into a vehicle- usually recombinant human or non-human virus.
•Advantages: –Choice of viral vector provides a high degree of efficacy and specificity –Many viral vectors are already approved for clinical trials –The shRNAs are control of the promoter of the viral vector and hence its expression can be regulated. |
|
is a process by which genetic information is transferred into a functional protein.
|
Gene expression
|